Postprandial inflammation: Targeting glucose and lipids

Advances in Experimental Medicine and Biology

Volumn 824, Issue , 2014, Pages 161-170

  De Vries, Marijke A ^a   Klop, Boudewijn ^a   Janssen, Hans W ^b   Njo, Tjin L ^b   Westerman, Elsbeth M ^a   Castro Cabezas, Manuel ^a  

^a Department of Internal Medicine Center for Diabetes and Vascular Medicine ^*  (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Adiposity; Apolipoprotein B48; Atherosclerosis; Chylomicron; Neutrophil; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHYLOMICRON; GLUCOSE; LIPID; PITAVASTATIN; SIMVASTATIN; VERY LOW DENSITY LIPOPROTEIN;

CELL ADHESION; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIFESTYLE MODIFICATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POSTPRANDIAL INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

EID: 84934435572     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-7320-0_12     Document Type: Review

References (71)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52.
2. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199-204.
3. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974;290:1275-8.
4. Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G, et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J. 2000;21:1081-90.
5. Muscari A, Bozzoli C, Puddu GM, Sangiorgi Z, Dormi A, Rovinetti C, et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med. 1995;98:357-64.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26.
7. Alipour A, van Oostrom AJHHM, Izraeljan A, Verseyden C, Collins JM, Frayn KN, et al. Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol. 2008;28:792-7.
8. Van Oostrom AJHHM, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HWM, De Jaegere PPT, et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis. 2004;177:175-82.
9. Sampson MJ, Davies IR, Brown JC, Ivory K, Hughes DA. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol. 2002;22:1187-93.
10. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045-51.
11. Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab. 2009;296:E1183-94.
12. Wang TY, Liu M, Portincasa P, Wang DQ-H. New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Investig. 2013;43:1203-23.
13. Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol Rev. 2012;92:1061-85.
14. Siddiqi S, Saleem U, Abumrad NA, Davidson NO, Storch J, Siddiqi SA, et al. A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER. J Lipid Res. 2010;51:1918-28.
15. Mansbach CM, Gorelick F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am J Physiol Gastrointest Liver Physiol. 2007;293:G645-50.
16. Mansbach CM, Siddiqi SA. The biogenesis of chylomicrons. Annu Rev Physiol. 2010;72:315-33.
17. Brunzell JD, Hazzard WR, Porte D, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973;52:1578-85.
18. Nakajima K, Nakano T, Tokita Y, Nagamine T, Inazu A, Kobayashi J, et al. Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin Chim Acta. 2011;412:1306-18.
19. Rustaeus S, Lindberg K, Stillemark P, Claesson C, Asp L, Larsson T, et al. Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation. J Nutr. 1999;129:463S-6.
20. Olofsson S-O, Borén J. Apolipoprotein B secretory regulation by degradation. Arterioscler Thromb Vasc Biol. 2012;32:1334-8.
21. Bjorkegren J, Packard CJ, Hamsten A, Bedford D, Caslake M, Foster L, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res. 1996;37:76-86.
22. Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC, Peelman F, et al. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis. 2010;211:1-8.
23. Wang YI, Bettaieb A, Sun C, Deverse JS, Radecke CE, Mathew S, et al. Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress. PLoS One. 2013;8:e78322.
24. Gower RM, Wu H, Foster GA, Devaraj S, Jialal I, Ballantyne CM, et al. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2011;31:160-6.
25. Higgins LJ, Rutledge JC. Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase. Curr Atheroscler Rep. 2009;11:199-205.
26. Van Oostrom AJHHM, Sijmonsma TP, Verseyden C, Jansen EHJM, de Koning EJP, Rabelink TJ, et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003;44:576-83.
27. Erridge C, Attina T, Spickett CM, Webb DJ. A highfat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86:1286-92.
28. Wanten G, van Emst-De Vries S, Naber T, Willems P. Nutritional lipid emulsions modulate cellular signaling and activation of human neutrophils. J Lipid Res. 2001;42:428-36.
29. Bentley C, Hathaway N, Widdows J, Bejta F, De Pascale C, Avella M, et al. Influence of chylomicron remnants on human monocyte activation in vitro. Nutr Metab Cardiovasc Dis. 2011;21:871-8.
30. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 1988;37:832-7.
31. Van Oostrom AJHHM, Plokker HWM, van Asbeck BS, Rabelink TJ, van Kessel KPM, Jansen EHJM, et al. Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis. Atherosclerosis. 2006;185:331-9.
32. Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, et al. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J Clin Invest. 1988;81:1332-40.
33. Bermudez B, Lopez S, Varela LM, Ortega A, Pacheco YM, Moreda W, et al. Triglyceride-rich lipoprotein regulates APOB48 receptor gene expression in human THP-1 monocytes and macrophages. J Nutr. 2012;142:227-32.
34. Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediat Inflamm. 2013;2013:152786.
35. Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, et al. Oxidized low- density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arter Thromb Vasc Biol. 2011;31:2090-7.
36. De M Bandeira S, da Fonseca LJS, da S Guedes G, Rabelo LA, Goulart MOF, Vasconcelos SML. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14:3265-84.
37. Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, Mohanty P, et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care. 2010;33:991-7.
38. Wang L, Guo L, Zhang L, Zhou Y, He Q, Zhang Z, et al. Effects of glucose load and nateglinide intervention on endothelial function and oxidative stress. J Diabetes Res. 2013;2013:849295.
39. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106:1319-31.
40. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol. 1994;267:E369-79.
41. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20.
42. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994;269:9889-97.
43. Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002;1:1.
44. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest. 1993;91:2155-68.
45. Fukami K, Yamagishi S-I, Okuda S. Role of AGEs- RAGE system in cardiovascular disease. Curr Pharm Des. 2014;20:2395-402.
46. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem. 2000;275:25781-90.
47. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med. 2003;198:1507-15.
48. Acosta J, Hettinga J, Flückiger R, Krumrei N, Goldfine A, Angarita L, et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A. 2000;97:5450-5.
49. Oka S-I, Hsu C-P, Sadoshima J. Regulation of cell survival and death by pyridine nucleotides. Circ Res. 2012;111:611-27.
50. Burton-Freeman B, Linares A, Hyson D, Kappagoda T. Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr. 2010;29:46-54.
51. Sardo CL, Kitzmiller JP, Apseloff G, Harris RB, Roe DJ, Stoner GD, et al. An open-label randomized crossover trial of lyophilized black raspberries on postprandial inflammation in older overweight males: a pilot study. Am J Ther. 2013. Epub ahead of print.
52. Yang J, Han Y, Chen C, Sun H, He D, Guo J, et al. EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-B signaling in human umbilical vein endothelial cells. Life Sci. 2013;92:589-97.
53. Ghanim H, Sia CL, Upadhyay M, Upadhyay M, Korzeniewski K, Viswanathan P, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr. 2010;91:940-9.
54. Burton-Freeman B, Talbot J, Park E, Krishnankutty S, Edirisinghe I. Protective activity of processed tomato products on postprandial oxidation and inflammation: a clinical trial in healthy weight men and women. Mol Nutr Food Res. 2012;56:622-31.
55. Blanco-Colio LM, Valderrama M, Alvarez-Sala LA, Bustos C, Ortego M, Hernández-Presa MA, et al. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation. 2000;102:1020-6.
56. Bellido C, López-Miranda J, Blanco-Colio LM, Pérez- Martínez P, Muriana FJ, Martín-Ventura JL, et al. Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men. Am J Clin Nutr. 2004;80:1487-91.
57. Camargo A, Delgado-Lista J, Garcia-Rios A, Cruz- Teno C, Yubero-Serrano EM, Perez-Martinez P, et al. Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people. Br J Nutr. 2012;108:500-8.
58. Li Z, Wong A, Henning SM, Zhang Y, Jones A, Zerlin A, et al. Hass avocado modulates postprandial vascular reactivity and postprandial inflammatory responses to a hamburger meal in healthy volunteers. Food Funct. 2013;4:384-91.
59. Bloomer RJ, Fisher-Wellman KH. Postprandial oxidative stress in exercise trained and sedentary cigarette smokers. Int J Environ Res Public Health. 2009;6:579-91.
60. Clegg M, McClean C, Davison WG, Murphy HM, Trinick T, Duly E, et al. Exercise and postprandial lipaemia: effects on peripheral vascular function, oxidative stress and gastrointestinal transit. Lipids Heal Dis. 2007;6:30.
61. Dixon NC, Hurst TL, Talbot DCS, Tyrrell RM, Thompson D. Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. J Appl Physiol. 2009;107:63-8.
62. Plat J, Jellema A, Ramakers J, Mensink RP. Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men. J Nutr. 2007;137:2635-40.
63. Corpeleijn E, Saris WHM, Jansen EHJM, Roekaerts PMHJ, Feskens EJM, Blaak EE. Postprandial interleukin- 6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss. J Clin Endocrinol Metab. 2005;90:5819-24.
64. Halkes CJ, van Dijk H, de Jaegere PP, Plokker HW, van Der Helm Y, Erkelens DW, et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol. 2001;21:1526-30.
65. Verseyden C, Meijssen S, van Dijk H, Jansen H, Castro Cabezas M. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia. J Lipid Res. 2003;44:2100-8.
66. Kakuda H, Kobayashi J, Nakato M, Takekoshi N. Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men. Cholesterol. 2013;2013:314170.
67. Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW. Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome. Atherosclerosis. 2008;198:381-8.
68. Okopie B, Krysiak R, Herman ZS. Effects of short- term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance. J Clin Endocrinol Metab. 2006;91:1770-8.
69. Van Wijk J, Coll B, Castro Cabezas M, Koning E, Camps J, Mackness B, et al. Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients. Clin Exp Pharmacol Physiol. 2006;33:1134-7.
70. Coll B, van Wijk JPH, Parra S, Castro Cabezas M, Hoepelman IM, Alonso-Villaverde C, et al. Effects of rosiglitazone and metformin on postprandial paraoxonase- 1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. Eur J Pharmacol. 2006;544:104-10.
71. Ceriello A, Novials A, Ortega E, Canivell S, La Sala L, Pujadas G, et al. Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care. 2013;36:2346-50.